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Desensitization protocols are increasing in food allergy
centers and a higher number of patients submitted to
these protocols have been showing a higher number of
adverse events even after well succeed procedure. The
aim of this study is to describe adverse reactions after
cow’s milk desensitization.
Methods
13 patients (3M: 10F, median age=11.8; 5.9-16.6) were
submitted to a protocol that includes twice in a week
increasing milk dose with initial dose calculated through
an end point test. Adverse reactions were described
according “Severity of Clinical Symptoms” by Sampson.
Results
Before desensitization protocol all patients had pre-
sented anaphylaxis, being 9 in the last year, regarding
accidental ingestion. Mean serum level of specific IgE to
milk and casein were 55.24 and 47.3, respectively. From
all well succeeded patients (200ml of milk at the end of
protocol,) 9 patients still presented isolated reactions,
being 3 Grade 1, 1 Grade 2, 0 grade 3, 5 Grade 4, 0
Grade 5. Only in 2 patients it was possible to detect a
risk factor associated, that was infection, NSAIs, fasting
and exercise, alcohol. In 2 patients the symptoms
decreased after fractioning milk ingestion.
Conclusion
Although desensitization procedures are a hope for a
new quality of life in these patients, more studies must
be developed to guarantee a really safe future for these
people.
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